Results 121 to 130 of about 2,886,776 (296)

Next‐generation proteomics improves lung cancer risk prediction

open access: yesMolecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj   +4 more
wiley   +1 more source

Use of open source software for dissemination and analysis of open government data [PDF]

open access: yes, 2017
Artigo apresentado no I Workshop de Informação, Dados e Tecnologia, realizado entre nos dias 04 e 06 de setembro de 2017, na cidade de Florianópolis (SC), no Auditório do Espaço Físico Integrado (EFI) da Universidade Federal de Santa Catarina (UFSC).O ...
Brito, Ronnie Fagundes   +3 more
core  

Open data, closed government: Unpacking data.gov.sg

open access: yesFirst Monday, 2019
In 2011, Singapore created data.gov.sg as an open, online repository for government data. This essay examines this Web portal, the data it contains, and some of the applications that have been built using it and aims to understand the role that data.gov.sg plays within the context of Singapore’s continued political and economic development.
openaire   +4 more sources

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Research on Linked Open Government Data and Application

open access: yesDianxin kexue, 2012
Open government data(OGD)is growing steadily and it has been a vital communication channel between government and citizens. Government data published by linked data technology can promote transparency and even improve reuse rate of data.
Yuanming Yuan, Chanle1 Wu, Haojun Ai
doaj   +2 more sources

Foreign technology summary of flight crucial flight control systems [PDF]

open access: yes, 1984
A survey of foreign technology in flight crucial flight controls is being conducted to provide a data base for planning future research and technology programs.
Rediess, H. A.
core   +1 more source

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

open access: yesMolecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad   +35 more
wiley   +1 more source

U.S. Government Open Internet Access to Sub-meter Satellite Data [PDF]

open access: yes
The National Geospatial-Intelligence Agency (NGA) has contracted United States commercial remote sensing companies GeoEye and Digital Globe to provide very high resolution commercial quality satellite imagery to federal/state government agencies and ...
Masek, Jeffery G.   +2 more
core   +1 more source

LINC01116, a hypoxia‐lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola   +12 more
wiley   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Home - About - Disclaimer - Privacy